Olema Pharmaceuticals, Inc. (OLMA)
16.80
-0.02
(-0.12%)
USD |
NASDAQ |
Apr 20, 14:29
Olema Pharmaceuticals SG&A Expense (Quarterly) : 6.864M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| EyePoint, Inc. | 11.38M |
| CytomX Therapeutics, Inc. | 7.36M |
| Corvus Pharmaceuticals, Inc. | 2.278M |
| Protagonist Therapeutics, Inc. | 11.43M |
| Oric Pharmaceuticals, Inc. | 8.695M |